169 related articles for article (PubMed ID: 14587872)
21. Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines.
Elliott J; Goodhew EB; Krug LT; Shakhnovsky N; Yoo L; Speck SH
J Virol; 2004 Dec; 78(24):14062-5. PubMed ID: 15564516
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
[TBL] [Abstract][Full Text] [Related]
23. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Profiling of EBV Gene Expression and Promoter Methylation Reveals Latency II Viral Infection and Sporadic Abortive Lytic Activation in Peripheral T-Cell Lymphomas.
Ho JWY; Li L; Wong KY; Srivastava G; Tao Q
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851637
[TBL] [Abstract][Full Text] [Related]
25. An origin of DNA replication (oriP) in highly methylated episomal Epstein-Barr virus DNA localizes to a 4.5-kb unmethylated region.
Falk K; Ernberg I
Virology; 1993 Aug; 195(2):608-15. PubMed ID: 8393238
[TBL] [Abstract][Full Text] [Related]
26. Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.
Schaefer BC; Strominger JL; Speck SH
Mol Cell Biol; 1997 Jan; 17(1):364-77. PubMed ID: 8972217
[TBL] [Abstract][Full Text] [Related]
27. Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus.
Fejer G; Koroknai A; Banati F; Györy I; Salamon D; Wolf H; Niller HH; Minarovits J
J Gen Virol; 2008 Jun; 89(Pt 6):1364-1370. PubMed ID: 18474551
[TBL] [Abstract][Full Text] [Related]
28. Wp specific methylation of highly proliferated LCLs.
Park JH; Jeon JP; Shim SM; Nam HY; Kim JW; Han BG; Lee S
Biochem Biophys Res Commun; 2007 Jun; 358(2):513-20. PubMed ID: 17499215
[TBL] [Abstract][Full Text] [Related]
29. Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA.
Minarovits J; Minarovits-Kormuta S; Ehlin-Henriksson B; Falk K; Klein G; Ernberg I
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1591-9. PubMed ID: 1649897
[TBL] [Abstract][Full Text] [Related]
30. Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines.
Jansson A; Masucci M; Rymo L
J Virol; 1992 Jan; 66(1):62-9. PubMed ID: 1370095
[TBL] [Abstract][Full Text] [Related]
31. Protein-DNA interaction and CpG methylation at rep*/vIL-10p of latent Epstein-Barr virus genomes in lymphoid cell lines.
Niller HH; Salamon D; Takacs M; Uhlig J; Wolf H; Minarovits J
Biol Chem; 2001 Oct; 382(10):1411-9. PubMed ID: 11727824
[TBL] [Abstract][Full Text] [Related]
32. De novo DNA methylation at nonrandom founder sites 5' from an unmethylated minimal origin of DNA replication in latent Epstein-Barr virus genomes.
Salamon D; Takacs M; Myöhänen S; Marcsek Z; Berencsi G; Minarovits J
Biol Chem; 2000 Feb; 381(2):95-105. PubMed ID: 10746740
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue.
Tao Q; Robertson KD; Manns A; Hildesheim A; Ambinder RF
Blood; 1998 Feb; 91(4):1373-81. PubMed ID: 9454768
[TBL] [Abstract][Full Text] [Related]
34. CTCF prevents the epigenetic drift of EBV latency promoter Qp.
Tempera I; Wiedmer A; Dheekollu J; Lieberman PM
PLoS Pathog; 2010 Aug; 6(8):e1001048. PubMed ID: 20730088
[TBL] [Abstract][Full Text] [Related]
35. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
36. Host-cell-phenotype-dependent control of the BCR2/BWR1 promoter complex regulates the expression of Epstein-Barr virus nuclear antigens 2-6.
Altiok E; Minarovits J; Hu LF; Contreras-Brodin B; Klein G; Ernberg I
Proc Natl Acad Sci U S A; 1992 Feb; 89(3):905-9. PubMed ID: 1371012
[TBL] [Abstract][Full Text] [Related]
37. Analysis of methylation patterns in the regulatory region of the latent Epstein-Barr virus promoter BCR2 by automated fluorescent genomic sequencing.
Takacs M; Myöhänen S; Altiok E; Minarovits J
Biol Chem; 1998; 379(4-5):417-22. PubMed ID: 9628332
[TBL] [Abstract][Full Text] [Related]
38. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage.
Kerr BM; Lear AL; Rowe M; Croom-Carter D; Young LS; Rookes SM; Gallimore PH; Rickinson AB
Virology; 1992 Mar; 187(1):189-201. PubMed ID: 1310556
[TBL] [Abstract][Full Text] [Related]
39. Replication licensing of the EBV oriP minichromosome.
Hirai K; Shirakata M
Curr Top Microbiol Immunol; 2001; 258():13-33. PubMed ID: 11443858
[TBL] [Abstract][Full Text] [Related]
40. The nucleotide polymorphisms within the Epstein-Barr virus C and Q promoters from nasopharyngeal carcinoma affect transcriptional activity in vitro.
Wang FW; Wu XR; Liu WJ; Liang YJ; Huang YF; Liao YJ; Shao CK; Zong YS; Mai SJ; Xie D
Eur Arch Otorhinolaryngol; 2012 Mar; 269(3):931-8. PubMed ID: 22146864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
